ENTECAVIR
- Product NDC
- 50268-289
- 11-digit product format
- 502680289
- Labeler code
- 50268
- Product ID
- 50268-289_d5cef9cd-9b5f-8bbc-e053-2995a90a2c7c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ENTECAVIR
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- AvPAK
- Application
- ANDA208782
- Marketing category
- ANDA
- Marketing start
- 2020-10-06
- Marketing end
- 0000-00-00
- Substance
- ENTECAVIR ANHYDROUS
- Active strength
- 1 mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Analog [EXT], Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50268-289-12 | 50268028912 | 20 BLISTER PACK in 1 BOX (50268-289-12) > 1 TABLET, FILM COATED in 1 BLISTER PACK (50268-289-11) | 20 blister pack | 2020-10-06 | 0000-00-00 | No | No | Current |